Eduard Gasal

Eduard joined Anaveon from Innovent Biologics (USA), Inc. where he served as CMO and President and was responsible for the clinical development strategy and execution outside of China. Prior to that he was Executive Director and Global Program Clinical Head at Novartis leading the cross functional clinical team for the melanoma, and prostate cancer franchise with main accountability for a large clinical development program consisting of more than 25 clinical studies (Phase I to Phase III) with targeted and immune-oncology compounds. Previously he served in roles of increasing responsibility at Amgen and Roche. Eduard has accumulated a wealth of experience across all aspects of clinical development, clinical operations and medical affairs during his career located in the United States and Switzerland, and has helped to bring several high-profile oncology drugs to market. He received his Master’s Degree and Medical Doctor Degree in Human Medicine from the University of Zurich in Switzerland.